Cargando…
Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches
PURPOSE: We investigate the impact of severe sensorineural hearing loss (SNHL) and for the first time evaluate the effect of unilateral versus bilateral SNHL on intellectual outcome in a cohort of children with embryonal brain tumors treated with and without radiation. METHODS: Data were from 94 chi...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525144/ https://www.ncbi.nlm.nih.gov/pubmed/34480430 http://dx.doi.org/10.1002/cam4.4245 |
_version_ | 1784585634433728512 |
---|---|
author | Moxon‐Emre, Iska Dahl, Christine Ramaswamy, Vijay Bartels, Ute Tabori, Uri Huang, Annie Cushing, Sharon L. Papaioannou, Vicky Laperriere, Normand Bouffet, Eric Mabbott, Donald J. |
author_facet | Moxon‐Emre, Iska Dahl, Christine Ramaswamy, Vijay Bartels, Ute Tabori, Uri Huang, Annie Cushing, Sharon L. Papaioannou, Vicky Laperriere, Normand Bouffet, Eric Mabbott, Donald J. |
author_sort | Moxon‐Emre, Iska |
collection | PubMed |
description | PURPOSE: We investigate the impact of severe sensorineural hearing loss (SNHL) and for the first time evaluate the effect of unilateral versus bilateral SNHL on intellectual outcome in a cohort of children with embryonal brain tumors treated with and without radiation. METHODS: Data were from 94 childhood survivors of posterior fossa (PF) embryonal brain tumors who were treated with either: (1) chemotherapy alone (n = 16, 7.11 [3.41] years, 11M/5F), (2) standard‐dose craniospinal irradiation (CSI) and/or large boost volumes (n = 44, 13.05 [3.26] years, 29M/15F), or (3) reduced‐dose CSI with a boost restricted to the tumor bed (n = 34, 11.07 [3.80] years, 19M/15F). We compared intellectual outcome between children who: (1) did and did not develop SNHL and (2) developed unilateral versus bilateral SNHL. A Chang grade of ≥2b that required the use of a hearing aid was considered severe SNHL. Comparisons were made overall and within each treatment group separately. RESULTS: Patients who developed SNHL had lower full scale IQ (p = 0.007), verbal comprehension (p = 0.003), and working memory (p = 0.02) than patients without SNHL. No differences were observed between patients who had unilateral versus bilateral SNHL (all p > 0.05). Patients treated with chemotherapy alone who developed SNHL had lower mean working memory (p = 0.03) than patients who did not develop SNHL. Among patients treated with CSI, no IQ indices differed between those with and without SNHL (all p > 0.05). CONCLUSIONS: Children treated for embryonal brain tumors who develop severe SNHL have lower intellectual outcome than patients with preserved hearing: this association is especially profound in young children treated with radiation sparing approaches. We also demonstrate that intellectual outcome is similarly impaired in patients who develop unilateral versus bilateral SNHL. These findings suggest that early intervention to preserve hearing is critical. |
format | Online Article Text |
id | pubmed-8525144 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85251442021-10-26 Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches Moxon‐Emre, Iska Dahl, Christine Ramaswamy, Vijay Bartels, Ute Tabori, Uri Huang, Annie Cushing, Sharon L. Papaioannou, Vicky Laperriere, Normand Bouffet, Eric Mabbott, Donald J. Cancer Med Clinical Cancer Researcher PURPOSE: We investigate the impact of severe sensorineural hearing loss (SNHL) and for the first time evaluate the effect of unilateral versus bilateral SNHL on intellectual outcome in a cohort of children with embryonal brain tumors treated with and without radiation. METHODS: Data were from 94 childhood survivors of posterior fossa (PF) embryonal brain tumors who were treated with either: (1) chemotherapy alone (n = 16, 7.11 [3.41] years, 11M/5F), (2) standard‐dose craniospinal irradiation (CSI) and/or large boost volumes (n = 44, 13.05 [3.26] years, 29M/15F), or (3) reduced‐dose CSI with a boost restricted to the tumor bed (n = 34, 11.07 [3.80] years, 19M/15F). We compared intellectual outcome between children who: (1) did and did not develop SNHL and (2) developed unilateral versus bilateral SNHL. A Chang grade of ≥2b that required the use of a hearing aid was considered severe SNHL. Comparisons were made overall and within each treatment group separately. RESULTS: Patients who developed SNHL had lower full scale IQ (p = 0.007), verbal comprehension (p = 0.003), and working memory (p = 0.02) than patients without SNHL. No differences were observed between patients who had unilateral versus bilateral SNHL (all p > 0.05). Patients treated with chemotherapy alone who developed SNHL had lower mean working memory (p = 0.03) than patients who did not develop SNHL. Among patients treated with CSI, no IQ indices differed between those with and without SNHL (all p > 0.05). CONCLUSIONS: Children treated for embryonal brain tumors who develop severe SNHL have lower intellectual outcome than patients with preserved hearing: this association is especially profound in young children treated with radiation sparing approaches. We also demonstrate that intellectual outcome is similarly impaired in patients who develop unilateral versus bilateral SNHL. These findings suggest that early intervention to preserve hearing is critical. John Wiley and Sons Inc. 2021-09-04 /pmc/articles/PMC8525144/ /pubmed/34480430 http://dx.doi.org/10.1002/cam4.4245 Text en © 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Cancer Researcher Moxon‐Emre, Iska Dahl, Christine Ramaswamy, Vijay Bartels, Ute Tabori, Uri Huang, Annie Cushing, Sharon L. Papaioannou, Vicky Laperriere, Normand Bouffet, Eric Mabbott, Donald J. Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches |
title | Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches |
title_full | Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches |
title_fullStr | Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches |
title_full_unstemmed | Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches |
title_short | Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches |
title_sort | hearing loss and intellectual outcome in children treated for embryonal brain tumors: implications for young children treated with radiation sparing approaches |
topic | Clinical Cancer Researcher |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525144/ https://www.ncbi.nlm.nih.gov/pubmed/34480430 http://dx.doi.org/10.1002/cam4.4245 |
work_keys_str_mv | AT moxonemreiska hearinglossandintellectualoutcomeinchildrentreatedforembryonalbraintumorsimplicationsforyoungchildrentreatedwithradiationsparingapproaches AT dahlchristine hearinglossandintellectualoutcomeinchildrentreatedforembryonalbraintumorsimplicationsforyoungchildrentreatedwithradiationsparingapproaches AT ramaswamyvijay hearinglossandintellectualoutcomeinchildrentreatedforembryonalbraintumorsimplicationsforyoungchildrentreatedwithradiationsparingapproaches AT bartelsute hearinglossandintellectualoutcomeinchildrentreatedforembryonalbraintumorsimplicationsforyoungchildrentreatedwithradiationsparingapproaches AT taboriuri hearinglossandintellectualoutcomeinchildrentreatedforembryonalbraintumorsimplicationsforyoungchildrentreatedwithradiationsparingapproaches AT huangannie hearinglossandintellectualoutcomeinchildrentreatedforembryonalbraintumorsimplicationsforyoungchildrentreatedwithradiationsparingapproaches AT cushingsharonl hearinglossandintellectualoutcomeinchildrentreatedforembryonalbraintumorsimplicationsforyoungchildrentreatedwithradiationsparingapproaches AT papaioannouvicky hearinglossandintellectualoutcomeinchildrentreatedforembryonalbraintumorsimplicationsforyoungchildrentreatedwithradiationsparingapproaches AT laperrierenormand hearinglossandintellectualoutcomeinchildrentreatedforembryonalbraintumorsimplicationsforyoungchildrentreatedwithradiationsparingapproaches AT bouffeteric hearinglossandintellectualoutcomeinchildrentreatedforembryonalbraintumorsimplicationsforyoungchildrentreatedwithradiationsparingapproaches AT mabbottdonaldj hearinglossandintellectualoutcomeinchildrentreatedforembryonalbraintumorsimplicationsforyoungchildrentreatedwithradiationsparingapproaches |